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ABSTRACT
Background: In the International Lipid-Based Nutrient Supplements (iLiNS)-DYAD-Ghana trial, prenatal small-quantity
lipid-based nutrient supplements (LNSs) had a positive effect on birth weight. Birth weight may be inversely related to
blood pressure (BP) later in life.
Objectives: We examined the effect of the intervention on BP at 4–6 y of age, and maternal and child factors related
to BP.
Methods: The iLiNS-DYAD-Ghana study was a partially double-blind, randomized controlled trial which assigned women
(n = 1320) ≤20 weeks of gestation to daily supplementation with: 1) iron and folic acid during pregnancy and 200 mg
Ca for 6 mo postpartum , 2) multiple micronutrients during pregnancy and postpartum, or 3) LNSs during pregnancy and
postpartum plus LNSs for infants from 6 to 18 mo of age. At 4–6 y of age (n = 858, 70% of live births), we compared
BP, a secondary outcome, between non-LNS and LNS groups and examined whether BP was related to several factors
including maternal BP, child weight-for-age z score (WAZ), and physical activity.
Results: Non-LNS and LNS groups did not differ in systolic (99.2 ± 0.4 compared with 98.5 ± 0.6 mm Hg; P = 0.317) or
diastolic (60.1 ± 0.3 compared with 60.0 ± 0.4 mm Hg; P = 0.805) BP, or prevalence of high BP (systolic or diastolic BP
≥90th percentile of the US National Heart, Lung, and Blood Institute reference: 31% compared with 28%; P = 0.251).
BP at 4–6 y of age was positively related to birth weight; this relation was largely mediated through concurrent WAZ in
a path model. Concurrent WAZ and maternal BP were the factors most strongly related to child BP.
Conclusions:Despite greater birth weight in the LNS group, there was no intervention group difference in BP at 4–6 y.
In this preschool population at high risk of adult hypertension based on BP at 4–6 y, high maternal BP and child WAZ
were key factors related to BP. This trial was registered at clinicaltrials.gov as NCT00970866. J Nutr 2019;149:522–531.
Keywords: supplementation, blood pressure, lipid-based nutrient supplements, Ghanaian children; prenatal; infant
nutrition
Introduction
The maternal intrauterine environment plays a key role in fetal
development and conditions the offspring for risk of certain
metabolic diseases later in life (1). Because fetal growth is
strongly influenced by nutrient and oxygen supply in utero,
prenatal nutrition is considered a key programming stimulus
(2). There is considerable evidence for an inverse relation
between birth weight and subsequent blood pressure (BP)
later in life (3), most of which comes from animal research
and human cohort studies (4). Low birth weight is associated
with a reduction in nephron number in humans (5, 6),
which may increase susceptibility to renal injury and thereby
affect BP. Besides birth weight, elevated BP and adiposity in
childhood are independent predictors of adult hypertension and
cardiovascular disease (7).
In children, hypertension is defined as systolic or diastolic BP
≥95th percentile and elevated BP as values ≥90th percentile and
<95th percentile (8). In a recent meta-analysis, the prevalence
of hypertension and elevated BP among 2- to 19-y-old African
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children was 5.5% and 12.7%, respectively (9). Results from
a meta-analysis and systematic review indicate that BP tracks
from childhood into adulthood (10) and 1 study reported that
even short periods of hypertension in childhood may increase
the risk of hypertension as an adult (11). The prevalence of adult
hypertension (defined as systolic BP ≥140 mm Hg or diastolic
BP ≥90 mm Hg) in Ghana is relatively high, ranging between
19.3% and 54.6% among adults (12), which parallels the
general trend towards chronic disease in a country undergoing
the nutrition transition. The double burden of undernutrition in
early life and subsequent exposure to risk factors for overweight
puts young children at high risk of later development of chronic
diseases. Interventions that can improve nutrition in early life
may thus help to prevent these consequences.
The International Lipid-Based Nutrient Supplements
(iLiNS)-DYAD trial in Ghana evaluated the effects of maternal
and child supplementation with small-quantity lipid-based
nutrient supplements (LNSs) on birth outcomes and child
growth. As reported previously, LNS supplementation had
a positive effect on birth weight (13) and weight and length
by 18 mo of age (14). The current study reports results
from a follow-up of the children from the iLiNS-DYAD trial at
4–6 y of age. The first objective of this analysis was to determine
the effect of LNS supplementation on systolic BP (SBP) and
diastolic BP (DBP). Because birth weight has been inversely
related to BP in later life, we hypothesized that children in the
LNS group would have lower BP than children in the control
groups. The second objective was to examine the maternal and
child factors related to BP in this cohort of preschool children,
including maternal BMI and BP, and child anthropometric
indexes, dietary variables, and physical activity.
Methods
Location and study design of the main trial
The iLiNS-DYAD-Ghana trial (NCT00970866) was conducted in the
Yilo and Lower Manya Krobo districts of the Eastern Region of Ghana
between December 2009 and March 2014. Details of the study are
published elsewhere (13). Briefly, the study was a partially double-
blind, randomized controlled trial that enrolled 1320 women 18 y
or older at ≤20 weeks of gestation attending antenatal clinics in
4 main health facilities in the study area. The women were randomly
assigned to 1 of 3 supplementation groups: 1) daily iron and folic acid
capsules during pregnancy, 200 mg/d calcium tablets (placebo) during
the first 6 mo postpartum, and no infant supplementation; 2) daily
multiple micronutrient capsules (1–2 times the RDA of 18 vitamins
and minerals) during pregnancy and the first 6 mo postpartum and
no infant supplementation; or 3) daily 20-g (118-kcal) LNSs during
pregnancy and the first 6 mo postpartum followed by infant LNS
supplementation from 6 to 18 mo of age. The maternal LNSs had the
same micronutrient content as the multiple micronutrient supplement,
plus calcium, magnesium, phosphorus, potassium, and macronutrients
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(essential fatty acids and a small amount of protein), whereas the infant
LNSs had the same macronutrients and 22 micronutrients based on
infant Recommended Nutrient Intakes (15). Women and children were
followed ≤6 mo postpartum and 18 mo of age, respectively. Growth
status of children was measured at birth, 6, 12, and 18 mo.
Follow-up when children were 4–6 y of age
Participants in the follow-up study (also NCT00970866) were the
children born to the pregnant women who were randomly assigned
into the trial. In the main trial, when a mother delivered twins, one of
the twins was randomly selected as the study child. All children who
were alive at the time of the follow-up study were potentially eligible
to participate. At follow-up, after excluding misdiagnosed pregnancies
(n = 5), miscarriages and stillbirths (n = 66), and child deaths before the
end of the main trial (n = 27), 1222 children were potentially eligible
to participate. Details of the study profile are shown in Figure 1.
The follow-up study protocols were approved by the Institutional
Review Board of University of California Davis; the Ethics Committee
for the College of Basic and Applied Sciences at the University of
Ghana; and the Ghana Health Service Ethical Review Committee.
Written informed consent was given by children’s primary caregivers
before data collection.
Data collection procedures.
Participants were contacted using the last known address and contact
number provided. Field staff called to set up an appointment and visited
the caregiver to obtain informed consent for the follow-up activities.
After consent had been given, participants were scheduled for the data
collection visits, the last of which was the laboratory visit, which took
place in a central location. BP measurements for mothers and children
were done in duplicate by a trained nurse and her assistant using
automated BP monitors (Riester ri-champion N, for children; Omron
BP742N, for mothers) with age-appropriate arm cuffs. Measurements
were done while the child was sitting with the child’s arm at their
chest level on a table and feet resting flat on a footstool. For mothers,
measurements were done following the same procedure as for children
except mothers had their feet on the floor. Participants rested (sitting)
for ≥5 min before measurements were taken.
Anthropometric measurements were taken according to WHO
standard procedures (16) by trained anthropometrists. Height was
measured using a stadiometer (Seca 217) to the nearest 0.1 cm, weight
using a scale (Seca 875) to the nearest 50 g. All measurements were
taken in duplicate and in triplicate if the first 2 measurements differed
by a predefined amount: 0.1 kg for weight and 0.5 cm for height.
Data on child food and beverage preferences and consumption,
with an emphasis on sweet foods and beverages, were collected by
administering a questionnaire to the caregiver (17). The questionnaire
asked about the number of times different food and beverage items (or
food and beverage groups) were consumed by the child in the week
preceding the interview. The reported numbers of times for each of
the items were summed up to obtain a score for total frequency of
consumption of sweet foods and beverages.
Anthropometry, BP measurements, and recall of child food and
beverage consumption were targeted for the full sample. Physical
activity was to be estimated in a random subsample of 630 (n = 420
and 210, non-LNS and LNS, respectively) children. Of this number, 376
children were fitted with a device and physical activity was successfully
estimated for 353 children (n = 224 and 129, non-LNS and LNS,
respectively). Every child in the subsample was fitted with a single
accelerometer (Actigraph GT3X) for 1 wk to estimate physical activity.
Accelerometers were fitted to an elastic belt and fastened to the child’s
right hip by trained data collectors. Caregivers were instructed to let
the child wear the accelerometer continuously day and night for the
1-wk period unless they experienced discomfort. Activity was stored
in 60-s intervals or epochs. Physical activity data were analyzed using
ActiLife data analysis software version 6.13.1 to generate mean vector
magnitude accelerometer counts per minute per participant.
All data collection staff were blinded to group assignments. The data
analyst remained blinded until all decisions regarding outliers for our
first objective had been made.
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1320 enrolled into main trial
Randomly assigned to
IFA
n = 441
MMN
n = 439
LNS
n = 440
Eligible for re-enrolment at age 4-6 y
n = 817
Eligible for re-enrolment at age 4-6 y
n = 405
Re-enrolled at age 4-6y
n = 662
Re-enrolled at age 4-6y
n = 352
Blood pressure measured
n = 557
Blood pressure measured
n = 301
Misdiagnosed pregnancy 
(n = 4)
Miscarriage (n = 12)
Still birth (n = 7)
Child died (n = 12)
Misdiagnosed 
pregnancy (n = 1)
Miscarriage (n = 25)
Still birth (n = 22) 
Child died (n = 15)
Not traced (n = 65)
Refused (n = 35)
Child died after 
main trial (n = 3)
Moved (n = 52)
Not traced (n = 31)
Refused (n = 8)
Child died after main 
trial (n = 2)
Moved (n = 12)
Lost to follow-up 
(n = 105)
Lost to follow-up 
(n = 51)
FIGURE 1 Study profile. IFA, iron and folic acid; LNS, lipid-based nutrient supplement; MMN, multiple micronutrients.
Sample size and data analysis.
For these analyses, our sample size was the 858 children who had BP
data at the 4–6 y follow-up. With this sample size we were powered to
detect a difference of 1.07 mm Hg in systolic BP (an effect size of 0.11,
based on the SD of 9.87) between the 2 groups (non-LNS and LNS) at
80% power.
For our first objective, to determine the effect of the intervention
on BP (a secondary objective of the study), a statistical analysis plan
was posted on the iLiNS Project website (www.ilins.org) before data
analysis. The primary outcomes for this analysis were SBP and DBP
and secondary outcomes were SBP and DBP z scores standardized
based on gender, age, and height, as well as high BP defined as SBP
or DBP ≥90th percentile of the reference population. BP percentiles
and z scores were calculated using the equations given in the National
Heart, Lung, and Blood Institute Fourth Report on the Diagnosis,
Evaluation, and Treatment of High Blood Pressure in Children and
Adolescents (8). Analysis was carried out based on the intention-
to-treat principle using SAS version 9.4 (SAS Institute) and all tests
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FIGURE 2 Conceptual model of maternal and child factors related to child blood pressure. WAZ, weight-for-age z score.
were 2-sided and considered significant at the 5% level. Because our
hypothesis was based on comparing the LNS group with the 2 non-
LNS groups, the primary analysis for the first objective was a 2-group
comparison. However, a sensitivity analysis was performed comparing
all 3 groups. The effect of the intervention on continuous outcomes was
examined using ANCOVA. Logistic regression was used for analysis
of categorical outcomes. For all analyses, we controlled for child age
at follow-up (minimally adjusted models). For fully adjusted models,
several prespecified covariates were considered for inclusion in addition
to child age: child sex, and maternal characteristics at enrollment in the
main trial (gestational age, nulliparity, BMI, and household asset score).
These additional covariates were included only if they were associated
with an outcome at a 10% level of significance in bivariate analysis.
Maternal SBP, DBP, and BMI at enrollment in the main trial, nulliparity,
and child sex were tested as effect modifiers, and if the interaction term
was significant (P-interaction <0.05) we conducted further analysis by
stratifying the intervention groups on categories of the effect modifier. In
addition, we conducted a per-protocol analysis by limiting the analysis
to mothers who self-reported ≥80% adherence to the supplements
during the pregnancy period.
For the second objective, to identify the factors related to BP in this
cohort of children, the analysis was based on the conceptual model in
Figure 2. The outcomes were SBP, DBP, mean arterial pressure (MAP),
and pulse pressure (PP) calculated as follows: MAP = DBP + [0.333
× (SBP − DBP)] and PP = SBP − DBP (18). We included MAP
and PP because they may be helpful in interpreting the relative role
of both arterial stiffness and vascular resistance in contributing to
cardiovascular disease risk (19). We examined the relation of each
of these outcomes to several maternal (maternal prepregnancy BMI,
maternal BP at enrollment and follow-up) and child [birth WAZ
(weight-for-age z score); postnatal weight gain (0–6 mo, i.e., difference
between weight at 6 mo and birth weight); concurrent WAZ, percentage
body fat, and BMI; sweet food and beverage intake at follow-
up; physical activity at follow-up] factors. Estimated prepregnancy
BMI was calculated from estimated prepregnancy weight (based on
polynomial regression with gestational age, gestational age squared,
and gestational age cubed as predictors) and height at enrollment (14).
All variables were standardized before analysis of the data. For each
model, the outcome and the factor were examined in an independent
regression model adjusting for child age in minimally adjusted models
and including in fully adjusted models other covariates (household
asset score at enrollment, maternal age, education, and nulliparity
at enrollment, child sex, and intervention group) if these covariates
were associated with the outcome at a 10% level of significance in
bivariate analysis. Household asset score was constructed based on
ownership of a set of assets (radio, television, refrigerator, and stove),
lighting source, drinking water supply, sanitation facilities, and flooring
materials, developed into an index (with a mean of 0 and SD of 1)
using principal components analysis (20). For each model, the value
of the covariate for observations that had high leverage (>0.02) was
truncated to the 2.5th or 97.5th percentile. We performed a sensitivity
analysis with and without truncation of the observations and indicated
where appropriate whether truncation made a difference to the results.
Normality of the residuals was tested with the Shapiro–Wilk test and
the linearity assumption was evaluated by plotting a residual against fit
scatterplot. We also examined how the factors related to each other.
First, for each path in the model, factor–outcome or factor–factor,
we removed any path that was nonsignificant (P < 0.10). Second,
for variables that were retained, we checked for mediation between
independent variables and the outcome according to the model in
Figure 2, using the binary mediation command in Stata version 15.0
(StataCorp) and we included any significant mediation pathways in the
overall path model. The mediators tested were child WAZ and BMI
z score at 4–6 y. Finally, for variables and pathways that were retained
in the first 2 steps, the overall model coefficients were estimated using
the SEM command in Stata specifying standardized coefficients and the
maximum likelihood for missing values method to account for missing
data. The overall path was modeled for only 1 outcome: child SBP.
Results
Of the 1222 children eligible to participate in the follow-up
study, we enrolled 662 and 352 in the non-LNS and LNS groups,
respectively, and measured BP for 557 in the non-LNS and 301
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TABLE 1 Background characteristics of women and children in the iLiNS-DYAD-Ghana trial
included in the follow-up1
Non-LNS (n = 557) LNS (n = 301)
Maternal characteristics at baseline
Age, y 26.7 ± 5.4 26.7 ± 5.5
Gestational age at enrolment, wk 16.0 ± 3.2 16.1 ± 3.4
Formal education, y 7.6 ± 3.4 7.6 ± 3.7
Married or cohabiting, % (n/N) 93.5 (521/557) 92.7 (279/301)
Asset score2 0.07 ± 0.94 − 0.11 ± 0.97
Nulliparous, % (n/N) 32.1 (179/557) 33.6 (101/301)
Weight, kg 61.5 ± 12.0 62.9 ± 12.4
Height, cm 158.8 ± 5.8 159.3 ± 5.4
Prepregnancy BMI,3 kg/m2 24.4 ± 4.5 24.8 ± 4.5
Overweight (BMI ≥ 25), % (n/N) 30.5 (166/545) 34.3 (102/297)
Systolic blood pressure, mm Hg 110.1 ± 10.8 110.7 ± 13.9
Diastolic blood pressure, mm Hg 62.3 ± 8.1 63.1 ± 9.3
Child characteristics
Birth weight, g 2962.5 ± 425.9 3019.9 ± 415.9
Current age of child, y 5.0 ± 0.6 5.1 ± 0.6
Sex of child, % male 46.8 50.2
Weight at 4–6 y, kg 16.4 ± 2.1 16.7 ± 2.3
Height at 4–6 y, cm 106.1 ± 5.4 107.0 ± 5.9
Height-for-age z score at 4–6 y − 0.30 ± 0.91 − 0.25 ± 0.99
BMI z score at 4–6 y − 0.57 ± 0.80 − 0.55 ± 0.82
Fat mass at 4–6 y, % 15.3 ± 4.6 15.2 ± 5.0
Fat-free mass at 4–6 y, % 84.9 ± 5.5 84.8 ± 5.1
1Values are means ± SDs unless otherwise stated. iLiNS, international lipid-based nutrient supplements; LNS, lipid-based nutrient
supplement group; non-LNS, IFA (iron and folic acid group) + MMN (multiple micronutrients group).
2Household asset score was constructed based on ownership of a set of assets and access to certain amenities using principal
components analysis.
3Estimated prepregnancy BMI was calculated from estimated prepregnancy weight (based on polynomial regression with gestational
age, gestational age squared, and gestational age cubed as predictors) and height at enrollment.
in the LNS group (70% of live births from the main trial; 84.6%
of re-enrolled children) by the end of the period for follow-up
data collection (January to December, 2016). The reasons for
nonparticipation were inability to trace the mother (n = 96),
consent refusal (n = 43), child death after the main trial ended
(n = 5), no longer residing in the study area (n = 64), and loss to
follow-up after enrollment in the follow-up (n = 156). Details
of the study flow are presented in Figure 1. There was a trend for
a difference in proportion lost to follow-up between the groups
(non-LNS: 36.7%; LNS: 31.6%, P = 0.07).
Maternal characteristics at enrollment into the main trial
for women in the current analysis are shown in Table 1. More
than 30% of the women were overweight (31% in the non-
LNS group and 34% in the LNS group, P = 0.035) and >90%
were married or cohabiting. The non-LNS group had a higher
household assets score than the LNS group (0.07 compared with
−0.11, P = 0.009) whereas the LNS women were heavier (61.5
compared with 62.9 kg, P = 0.035). About half the children
were male and mean ± SD age was 5.0 ± 0.6 y. There were
no significant differences in maternal enrollment characteristics
between those included in this analysis (n = 858) and those lost
to follow-up (Supplemental Table 1).
Mean ± SD SBP and DBP of children at 4–6 y were
99.0 ± 9.9 and 60.1 ± 6.7 mm Hg, respectively, and prevalence
of high BP was 30.4%. Continuous and categorical BP outcomes
adjusted for age are shown in Tables 2 and 3, respectively. There
were no significant differences between the intervention groups
for any of the BP outcomes. The aforementioned results did not
change after adjusting for additional prespecified covariates.
The sensitivity analysis revealed no significant differences in the
3-group comparisons for any of the continuous (Supplemental
Table 2) or categorical (Supplemental Table 3) outcomes.
Tests for interaction showed no significant (P < 0.05)
interactions of intervention group with any of the following
TABLE 2 Comparison of continuous BP measurements of children in the iLiNS-DYAD-Ghana trial
follow-up at 4–6 y1
Non-LNS (n = 557) LNS (n = 300) P value Difference in mean (95% CI)
SBP, mm Hg 99.2 ± 0.4 98.5 ± 0.6 0.317 0.71 (−0.68, 2.09)
SBP z score 0.67 ± 0.04 0.59 ± 0.05 0.199 0.09 (−0.05, 0.22)
DBP, mm Hg 60.1 ± 0.3 60.0 ± 0.4 0.805 0.12 (−0.83, 1.07)
DBP z score 0.69 ± 0.03 0.69 ± 0.04 0.891 0.01 (−0.08, 0.09)
1Values represent means ± SEs and differences in means (95% CIs). Values in the table are adjusted for child age. Results are
based on ANCOVA (SAS PROC GLIMMIX). BP, blood pressure; DBP, diastolic blood pressure; iLiNS, international lipid-based nutrient
supplements; LNS, lipid-based nutrient supplements group; non-LNS, IFA (iron and folic acid group) + MMN (multiple micronutrients
group); SBP, systolic blood pressure.
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TABLE 3 Comparison of categorical BP outcomes of children in the iLiNS-DYAD-Ghana trial
follow-up at 4–6 y1
Non-LNS (n = 536) LNS (n = 289) P value OR (95% CI)
Prehypertensive/hypertensive
(SBP ≥ 90th percentile)
Prevalence, % 26.3 22.2 0.146 0.78 (0.55, 1.09)
Prehypertensive/hypertensive
(DBP ≥ 90th percentile)
Prevalence, % 14.4 14.2 0.999 1.00 (0.66, 1.51)
Prehypertensive/hypertensive
(SBP or DBP ≥ 90th percentile)
Prevalence, % 31.7 28.0 0.251 0.83 (0.61, 1.14)
1Values are the percentage of participants whose response was “yes” for the outcome in question and OR (95% CI) obtained by
comparing the groups. Reference = non-LNS group for all outcomes. Values in the table are adjusted for child age. Results are based
on logistic regression (SAS PROC GLIMMIX). BP, blood pressure; DBP, diastolic blood pressure; iLiNS, international lipid-based nutrient
supplements; LNS, lipid-based nutrient supplements group; non-LNS, IFA (iron and folic acid group) + MMN (multiple micronutrients
group); SBP, systolic blood pressure.
variables at baseline: maternal prepregnancy BMI, maternal
SBP or DBP, nulliparity, and child sex (data not shown). When
the analysis was restricted to mothers who reported ≥80%
adherence during the pregnancy period (n = 316 in the non-
LNS group and n = 134 in the LNS group), we observed a
marginally significantly higher SBP in the non-LNS group than
in the LNS group (99.6 ± 0.6 compared with 97.7 ± 0.9 mm
Hg; P = 0.06), a borderline significant difference in SBP z score
(0.70 ± 0.05 compared with 0.51 ± 0.08; P = 0.049), and a
marginally significant difference in the prevalence of high BP
(34.9% compared with 26.2%; P = 0.08). The results remained
the same in the adjusted analysis (data not shown). There was
no difference in any of the outcomes for the sensitivity analyses
among high adherers (data not shown).
Summary statistics for the variables used in the analyses for
objective 2 are presented in Supplemental Table 4. WAZ at 4–
6 y was positively associated with sweet food and beverage
intake [β (SE) = 0.07 (0.03), P = 0.018], WAZ at birth was
inversely associated with postnatal weight gain [β (SE) = −0.07
(0.04), P = 0.07], and WAZ and BMI at 4–6 y were positively
associated [β (SE) = 0.65 (0.02), P < 0.0001]. The relation
between BMI at 4–6 y and sweet food and beverage intake was
nonsignificant [β (SE) = 0.02 (0.03), P = 0.53].
Table 4 shows the associations between each independent
factor and each outcome, adjusting only for child age. SBP, DBP,
PP, and MAP were all positively associated (P < 0.10) with
postnatal weight gain, WAZ at 4–6 y, BMI z scores at 4–6 y, and
maternal SBP and DBP at follow-up. In addition, child SBP and
MAP were positively associated with WAZ at birth and sweet
food and beverage intake, whereas child DBP and MAP were
positively associated with maternal SBP and DBP at enrollment.
For the path analysis, we modeled the overall path only
for SBP because of the 4 outcomes, the β-coefficients for the
associations with the predictors were highest for SBP and
MAP but SBP is measured more commonly than MAP. We
also included maternal BP at follow-up and not enrollment
because the enrollment measures were not significantly related
to child SBP. Maternal SBP at enrollment and follow-up were,
TABLE 4 Associations between outcomes (child SBP, DBP, PP, and MAP) and each factor in the iLiNS-DYAD-Ghana trial follow-up at
4–6 y1
SBP DBP PP MAP
Factors β (SE) P value β (SE) P value β (SE) P value β (SE) P value
WAZ at birth 0.08 (0.04) 0.026 0.06 (0.04) 0.132 0.04 (0.04) 0.223 0.08 (0.04) 0.035
Postnatal weight gain (0–6 mo)2 0.10 (0.04) 0.004 0.06 (0.04) 0.085 0.08 (0.04) 0.035 0.09 (0.04) 0.012
WAZ at 4–6 y 0.29 (0.04) <0.0001 0.23 (0.04) <0.0001 0.16 (0.04) <0.0001 0.29 (0.04) <0.0001
BMI z score at 4–6 y 0.21 (0.04) <0.0001 0.17 (0.04) 0.0002 0.12 (0.04) 0.006 0.20 (0.04) <0.0001
Percentage fat mass at 4–6 y − 0.04 (0.04) 0.260 0.02 (0.04) 0.638 − 0.05 (0.04) 0.145 − 0.01 (0.04) 0.846
Physical activity3 at 4–6 y 0.04 (0.06) 0.465 0.05 (0.06) 0.345 0.01 (0.06) 0.802 0.06 (0.06) 0.331
Sweet food and drink intake 0.06 (0.03) 0.062 0.04 (0.03) 0.206 0.04 (0.03) 0.282 0.06 (0.03) 0.084
Maternal SBP at enrollment 0.05 (0.03) 0.124 0.08 (0.03) 0.016 − 0.01 (0.03) 0.881 0.07 (0.03) 0.034
Maternal SBP at follow-up 0.13 (0.03) 0.0002 0.16 (0.03) <0.0001 0.03 (0.03) 0.316 0.16 (0.03) <0.0001
Maternal DBP at enrollment 0.05 (0.04) 0.130 0.13 (0.03) 0.0002 − 0.04 (0.03) 0.233 0.10 (0.10) 0.002
Maternal DBP at follow-up 0.12 (0.03) 0.0008 0.16 (0.03) <0.0001 0.02 (0.03) 0.593 0.15 (0.03) <0.0001
Maternal prepregnancy4 BMI 0.04 (0.03) 0.260 0.05 (0.03) 0.184 0.01 (0.03) 0.882 0.05 (0.03) 0.185
1Values in the table are coefficients (SEs) from separate models of each independent factor with each outcome, adjusted only for child age. Coefficients are standardized. Results
are based on regression (SAS PROC REG). DBP, diastolic blood pressure; iLiNS, international lipid-based nutrient supplements; MAP, mean arterial pressure; PP, pulse pressure,
SBP, systolic blood pressure; WAZ, weight-for-age z score.
2Postnatal weight gain = weight at 6 mo − birth weight.
3Physical activity was estimated as vector magnitude count per minute.
4Estimated prepregnancy BMI was calculated from estimated prepregnancy weight (based on polynomial regression with gestational age, gestational age squared, and gestational
age cubed as predictors) and height at enrollment.
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FIGURE 3 Final path model of the maternal and child factors related to child systolic blood pressure at 4–6 y. Numbers in the model are
standardized β-coefficients. ∗∗P > 0.0001 but P < 0.001; ∗∗∗P < 0.0001. SBP, systolic blood pressure; WAZ, weight-for-age z score.
however, correlated with each other [correlation coefficient
(r) = 0.47; P < 0.0001]. Child BMI z score and WAZ at 4–
6 y were highly correlated (r > 0.65; P < 0.0001) but the β-
coefficient for the association of child BMI z score with SBP
was lower than that for WAZ, so BMI z score was dropped
from the final model. In the final path model (Figure 3), WAZ at
4–6 y and maternal concurrent SBP remained positively
associated with child SBP. Birth WAZ and postnatal weight gain
were not significantly associated with child SBP in the path
model even though both factors were significantly associated
with child SBP in a regression analysis controlling only for child
age. Maternal prepregnancy BMI was significantly associated
with both child WAZ at follow-up (4–6 y) and maternal SBP at
follow-up.
Birth WAZ, postnatal weight gain, and sweet food and
beverage intake were also positively associated with child WAZ
at 4–6 y. WAZ at 4–6 y was a significant mediator of the
relations between birth WAZ and child SBP and between
postnatal weight gain and child SBP. Figure 4A illustrates the
relation between birth WAZ and child SBP mediated by WAZ
at 4–6 y. Birth WAZ was positively associated with WAZ at
4–6 y in a fully adjusted model. Child SBP was positively
associated with WAZ at 4–6 y but not with birth WAZ. In
Figure 4B we examine WAZ at 4–6 y as a mediator between
postnatal weight gain and child SBP. Postnatal weight gain
was positively associated with WAZ at 4–6 y whereas SBP
at 4–6 y was inversely associated with postnatal weight gain
but positively associated with WAZ at 4–6 y. Birth WAZ
was a significant mediator of the relation between maternal
prepregnancy BMI and WAZ at 4–6 y (Figure 4C). However,
the direct association between maternal prepregnancy BMI and
WAZ at 4–6 y also remained significant.
Discussion
Because increased birth weight has been associated with lower
BP later in life (21–30), and the provision of LNSs during
pregnancy increased birth weight in the iLiNS-DYAD-Ghana
trial (13), we hypothesized that children in the LNS group
would have lower BP at 4–6 y than those in the non-LNS
group. The primary results did not support this hypothesis:
we observed no effect of LNSs provided to mothers prenatally
and in the first 6 mo of lactation and to children from 6 to
18 mo of age on child BP in this follow-up of the iLiNS-
DYAD-Ghana cohort. However, in the per-protocol analysis
among high adherers (≥80% adherence during pregnancy), we
A
SBP at 4–6 yBirth WAZ
WAZ at 4–6 y
0.32 (0.03)*** 0.31 (0.06)***
-0.00 (0.04)
C
WAZ at 4–6 yMaternal BMI 
at enrollment
Birth WAZ0.18 (0.03)*** 0.26 (0.03)***
0.13 (0.03)***
B
SBP at 4–6 y
Postnatal 
weight gain 
WAZ at 4–6 y0.48 (0.02)***
-0.05 (0.05)
0.31 (0.06)***
FIGURE 4 Path diagrams representing mediation analysis within
the final path model. (A) Mediation between birth WAZ and SBP
at 4–6 y by WAZ at 4–6 y. Parameter estimates of mediation:
0.08 (0.02)∗∗∗; proportion mediated 97.2%. (B) Mediation between
postnatal weight gain (0–6 mo) and SBP at 4–6 y by WAZ at 4–
6 y. Parameter estimates of mediation: 0.13 (0.03)∗∗∗; proportion
mediated 75.6%. (C) Mediation between maternal prepregnancy BMI
and WAZ at 4–6 y by birth WAZ. Parameter estimates of mediation:
0.07 (0.02)∗∗∗; proportion mediated 25.9%. Numbers in the model
were obtained from mediation analysis in STATA software version 15.0
and represent parameter estimates (SEs). ∗∗∗P < 0.0001. SBP, systolic
blood pressure; WAZ, weight-for-age z score.
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observed lower SBP z score (P < 0.05), SBP, and prevalence of
high BP (P < 0.10) in the LNS group. There was a high overall
prevalence of high BP (30%) among the children. Child BP at
4–6 y was significantly associated with concurrently measured
maternal SBP and child WAZ. Birth weight and postnatal weight
gain (0–6 mo of age) were both related indirectly to child SBP
via their positive associations with child WAZ at 4–6 y.
Strengths of our study include the large sample size and the
blinding of field staff (study nurses and anthropometrists) to
group assignment. A potential limitation is that loss to follow-
up was somewhat higher in the non-LNS group. However,
there were no differences in characteristics between the sample
included in this analysis and those lost to follow-up, suggesting
that our conclusions are generalizable to the full cohort.
Another limitation is that the non-LNS group had a lower
household asset score and a higher percentage of maternal
overweight than the LNS group. However, we adjusted for
asset score, maternal prepregnancy BMI, and other prespecified
covariates in our analysis. A further limitation is that we
did not measure certain dietary factors associated with BP,
such as sodium intake. Although we did not measure BP
by the recommended auscultation procedure (manual BP cuff
and stethoscope), we used a validated oscillometric device
(automated BP cuff). We also used appropriately sized cuffs
(child and adult) for the measurement of BP and allowed
participants to rest for ≥5 min before measurements were taken
to prevent artificially elevated values.
Our primary results are consistent with those of a previous
trial providing both prenatal and postnatal nutrition supple-
mentation that included a long-term follow-up: the INCAP
Longitudinal Study in Guatemala (31). The investigators found
no independent effect of the supplements (Atole compared
with Fresco, intervention compared with control supplement)
on SBP or DBP in young adulthood. Results of other
follow-up studies, in which the intervention included only
prenatal supplementation (with food or micronutrients) (32–
38), have been mixed. Two trials in Nepal examined the effect
of maternal micronutrient supplementation on offspring BP
(33, 37, 38). One showed lower SBP but not DBP in the
multiple micronutrient group than in the control group when
the children were 2.5 y of age (38), but no difference at
8.5 y (33). The other trial showed no difference in BP when
children were ∼7.5 y of age (37). Four other trials involved
prenatal food supplementation (with or without micronutrient
supplements) (34, 36) or prenatal calcium supplementation (32,
35); 3 indicated no effect on child BP, but 1 of the calcium trials
(32) showed lower SBP and lower risk of hypertension in the
calcium group than in the placebo group. Although we cannot
directly compare the results of these trials to ours because of
differences in study design, all except the latter trial agree with
our results showing no main effect of prenatal or postnatal
supplementation on later BP. It is important to note that the
increase in birth weight observed in the LNS group in the main
iLiNS-DYAD-Ghana trial was <100 g, whereas the magnitude
of the association between birth weight and later BP reported
in observational studies was a decrease of 1–4 mm Hg in BP
for every 1-kg increase in birth weight (25, 26, 30). Thus,
the increase in birth weight resulting from prenatal nutrition
interventions may not be large enough to lead to a detectable
difference in BP later in life.
The prevalence of high BP was 30% in this cohort, which
is similar to the prevalence observed in a Spanish population
of 4- to 6-y-old children: 27.5% in boys and 30.6% in
girls (18). In a study of 5- to 8-y-old children in Brazil,
the investigators used 2 different definitions for prevalence of
prehypertension/hypertension, based on elevated SBP (35%) or
elevated DBP (5%) (39). When we considered prehyperten-
sion/hypertension due only to elevated SBP, prevalence was 25%
(data not shown) in our cohort, which is lower than in Brazil
(39), but when based only on elevated DBP, prevalence was
14%, higher than the 5% rate reported in Brazil.
We did not observe an inverse relation between birth
weight and SBP in this cohort as has been reported in
several prospective cohort studies (21, 22, 25, 26, 28–30)
and a systematic review (3). Rather, we found a positive
relation between birth WAZ and BP at 4–6 y in regression
analysis controlling only for child age. Similar results have
been reported for an Aboriginal community where low birth
weight individuals had lower weight, height, BMI, cholesterol
concentration, and BP at 20–38 y compared to normal birth
weight individuals (40) and in the Pelotas, Brazil birth cohort
where SBP and DBP at 11 y were positively associated with birth
weight and length (41). However, in the Pelotas cohort, further
adjustment for several covariates and current BMI resulted
in an inverse association of birth weight with SBP. When we
adjusted for WAZ or BMI at 4–6 y the relation between birth
WAZ and child SBP did not become inverse. Thus, our results
do not support the hypothesis that low birth weight is a risk
factor for hypertension later in life. The mean birth weight in
our study was 3.0 kg, comparable to the mean birth weight
of ≥3 kg in most of the studies (22, 26, 28–30) reporting an
inverse association between birth weight and BP, except for
2 studies with lower mean birth weights (21, 25). However,
in our cohort the prevalence of low birth weight was low
and at 4–6 y the prevalence of overweight was low, which
may explain why we did not observe an inverse association
between birth weight and BP. In addition, although the
prevalence of overweight in our cohort was low, the prevalence
of elevated BP was high, suggesting that in this population
factors other than body size may also be critical determinants
of BP.
We observed a positive association between postnatal weight
gain (0–6 mo) and all BP outcomes at 4–6 y in regression
analysis controlling only for age, similar to the findings of the
Manchester Children’s Growth and Vascular Health study (42),
which showed that change in weight from birth to 3 mo of age
in children of South Asian and Caucasian origin was positively
associated with SBP at 12 mo of age. A similar result was also
observed in a prospective cohort in Amsterdam, in which faster
relative weight gain after the first month was associated with
higher SBP and DBP at 5 y of age (43).
We found that child WAZ at 4–6 y of age largely mediated
the associations of both birth WAZ and postnatal weight gain
with BP at 4–6 y, suggesting that current size is a more important
determinant than body size or growth in infancy. In addition
to WAZ, BMI z score at 4–6 y was positively associated with
BP in a regression analysis controlling only for age, but the
association with BMI z score was not significant when WAZ was
taken into account. Other studies have also reported a positive
association between BMI and BP in children (28, 44, 45). In
children and adolescents, the normal range of BP depends on
body size and age (8). We did not observe a relation between
percentage body fat and BP in this cohort of children, although
BMI was associated with BP, suggesting that the association is
driven by overall weight. In the Amsterdam Born Child and their
Development study, which examined ethnic differences in the
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relations of children’s BP to BMI, waist-to-height ratio, and fat
mass index, the strongest association was observed for BMI, and
the associations of BP with BMI and fat mass index differed by
ethnicity (46).
We also found a positive association between maternal BP
(at both baseline and follow-up) and child BP, although the
association was stronger with maternal BP at follow-up. In
the Generation R prospective cohort study in the Netherlands
(47), maternal BP at all time points in pregnancy (early, mid-,
and late pregnancy) was positively associated with childhood
BP at 6 y, with the strongest association observed with early
pregnancy maternal SBP. A similar result was observed in the
Avon Longitudinal Study of Parents and Children in the United
Kingdom, in which higher maternal BP in early pregnancy
was associated with higher child BP at 7 y (48). The study
investigators concluded that the observed association may be
driven by shared genetic or environmental factors.
In the final path model accounting for all factors, there
was no direct relation between SBP and either birth WAZ
or postnatal weight gain. These 2 early-life factors operated
through current WAZ, which was the strongest factor directly
related to BP at preschool age. Postnatal weight gain was
a stronger predictor of current WAZ than was birth WAZ.
Sweet food and drink consumption at 4–6 y and maternal
prepregnancy BMI were also positively related to current WAZ,
and maternal prepregnancy BMI was also related to maternal
BP. We did not observe a direct relation between maternal
prepregnancy BMI and child SBP but we observed a significant
relation between WAZ at age 4–6 y and child SBP. A recent
systematic review (49) suggested that the relation between
maternal prepregnancy body weight and offspring BP may be
an indirect effect mediated through offspring anthropometric
status, as we observed. To further understand the relation
between maternal prepregnancy BMI and WAZ at age 4–6 y, we
tested birth WAZ as a mediator of the relation. Birth WAZ was
a significant mediator but the direct relation between maternal
prepregnancy BMI and WAZ at 4–6 y also remained significant,
indicating the relation between maternal prepregnancy BMI and
WAZ at 4–6 y is not solely driven by WAZ at birth.
In conclusion, we did not find a difference in BP between the
intervention groups at the 4–6 y follow-up in the iLiNS-DYAD-
Ghana cohort, which is consistent with findings from previous
trials. Our results indicate that this preschool population is
at high risk of hypertension in later life. Child weight and
maternal BP were directly and significantly related to child
BP. Given that BP tends to remain consistent from childhood
to adulthood, further follow-up of this population would be
informative. These results suggest the need to evaluate the
environmental and lifestyle factors that increase the risk of
noncommunicable diseases in this population, in order to design
effective intervention strategies.
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